Proteomic profiling of 13 paired ductal infiltrating breast carcinomas and non‐tumoral adjacent counterparts

According to recent statistics, breast cancer remains one of the leading causes of death among women in Western countries. Breast cancer is a complex and heterogeneous disease, presently classified into several subtypes according to their cellular origin. Among breast cancer histotypes, infiltrating ductal carcinoma represents the most common and potentially aggressive form. Despite the current progress achieved in early cancer detection and treatment, including the new generation of molecular therapies, there is still need for identification of multiparametric biomarkers capable of discriminating between cancer subtypes and predicting cancer progression for personalized therapies. One established step in this direction is the proteomic strategy, expected to provide enough information on breast cancer profiling. To this aim, in the present study we analyzed 13 breast cancer tissues and their matched non‐tumoral tissues by 2‐DE. Collectively, we identified 51 protein spots, corresponding to 34 differentially expressed proteins, which may represent promising candidate biomarkers for molecular‐based diagnosis of breast cancer and for pattern discovery. The relevance of these proteins as factors contributing to breast carcinogenesis is discussed.

[1]  Otto Warburn,et al.  THE METABOLISM OF TUMORS , 1931 .

[2]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[3]  H. Jörnvall,et al.  Analysis of polypeptide expression in benign and malignant human breast lesions , 1997, Electrophoresis.

[4]  W. Donegan.  Tumor‐related prognostic factors for breast cancer , 1997, CA: a cancer journal for clinicians.

[5]  M A Sirover,et al.  New insights into an old protein: the functional diversity of mammalian glyceraldehyde-3-phosphate dehydrogenase. , 1999, Biochimica et biophysica acta.

[6]  H. Rochefort,et al.  Cathepsin D in breast cancer: mechanisms and clinical applications, a 1999 overview. , 2000, Clinica chimica acta; international journal of clinical chemistry.

[7]  M. V. van Hemert,et al.  14‐3‐3 proteins: key regulators of cell division, signalling and apoptosis , 2001, BioEssays : news and reviews in molecular, cellular and developmental biology.

[8]  P. Savagner,et al.  Leaving the neighborhood: molecular mechanisms involved during epithelial‐mesenchymal transition , 2001, BioEssays : news and reviews in molecular, cellular and developmental biology.

[9]  M. Maines,et al.  Nuclear localization of biliverdin reductase in the rat kidney: response to nephrotoxins that induce heme oxygenase-1. , 2001, The Journal of pharmacology and experimental therapeutics.

[10]  A. Yu,et al.  The association of 14-3-3gamma and actin plays a role in cell division and apoptosis in astrocytes. , 2002, Biochemical and biophysical research communications.

[11]  M. Maines,et al.  Human Biliverdin Reductase Is a Leucine Zipper-like DNA-binding Protein and Functions in Transcriptional Activation of Heme Oxygenase-1 by Oxidative Stress* , 2002, The Journal of Biological Chemistry.

[12]  Simona Fontana,et al.  Proteomic Patterns of Cultured Breast Cancer Cells and Epithelial Mammary Cells , 2002, Annals of the New York Academy of Sciences.

[13]  A contribution to breast cancer cell proteomics: Detection of new sequences , 2002, Proteomics.

[14]  Sang Won Kang,et al.  Peroxiredoxins in breast carcinoma. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[15]  H. Hermeking.  The 14-3-3 cancer connection , 2003, Nature Reviews Cancer.

[16]  S. Shenolikar,et al.  PP1 control of M phase entry exerted through 14‐3‐3‐regulated Cdc25 dephosphorylation , 2003, The EMBO journal.

[17]  Clark S. Phillipson,et al.  Impaired p53 expression, function, and nuclear localization in calreticulin-deficient cells. , 2004, Molecular biology of the cell.

[18]  T. Isono,et al.  Diagnostic potential in bladder cancer of a panel of tumor markers (calreticulin, γ‐synuclein, and catechol‐o‐methyltransferase) identified by proteomic analysis , 2004, Cancer science.

[19]  M. Maines,et al.  Biliverdin Reductase, a Novel Regulator for Induction of Activating Transcription Factor-2 and Heme Oxygenase-1* , 2004, Journal of Biological Chemistry.

[20]  Sui Huang,et al.  Components of U3 snoRNA-containing complexes shuttle between nuclei and the cytoplasm and differentially localize in nucleoli: implications for assembly and function. , 2003, Molecular biology of the cell.

[21]  D. Lodygin,et al.  The role of epigenetic inactivation of 14-3-3σ in human cancer , 2005, Cell Research.

[22]  Richard A. Miller,et al.  The thioredoxin reductase/thioredoxin system: Novel redox targets for cancer therapy , 2005, Cancer Biology & Therapy.

[23]  Stephen Russell,et al.  Proteomics of breast carcinoma. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[24]  D. Nowak,et al.  Beta-actin in human colon adenocarcinoma cell lines with different metastatic potential. , 2005, Acta biochimica Polonica.

[25]  E. Keller,et al.  The biology of a prostate cancer metastasis suppressor protein: Raf kinase inhibitor protein , 2005, Journal of cellular biochemistry.

[26]  Y. Li,et al.  Identification and analysis of tumour-associated antigens in hepatocellular carcinoma , 2005, British Journal of Cancer.

[27]  M. Maines,et al.  Human biliverdin reductase: a member of the insulin receptor substrate family with serine/threonine/tyrosine kinase activity. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[28]  Qing‐Yu He,et al.  Comparative proteomic analysis of esophageal squamous cell carcinoma , 2005, Proteomics.

[29]  Chao Xu,et al.  NMR structure and regulated expression in APL cell of human SH3BGRL3 , 2005, FEBS letters.

[30]  S. Larson,et al.  18F-2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography Scanning Affects Surgical Management in Selected Patients With High-Risk, Operable Breast Carcinoma , 2006, Annals of Surgical Oncology.

[31]  E. Dees,et al.  Targeting the ubiquitin-proteasome pathway in breast cancer therapy. , 2006, Future oncology.

[32]  M. Becchi,et al.  Expanding the protein catalogue in the proteome reference map of human breast cancer cells , 2006, Proteomics.

[33]  Susumu Goto,et al.  Effects of post-electrophoretic analysis on variance in gel-based proteomics , 2006, Expert review of proteomics.

[34]  Yusuke Nakamura,et al.  Overexpression of Peptidyl-Prolyl Isomerase-Like 1 Is Associated with the Growth of Colon Cancer Cells , 2006, Clinical Cancer Research.

[35]  D. Nandi,et al.  The ubiquitin-proteasome system , 2006, Journal of Biosciences.